Selective COX-2 Inhibitors Significantly Reduce the Occurrence of Heterotopic Ossification After Hip Arthroscopic Surgery
Conclusion:
HO after hip arthroscopic surgery is a relatively common complication, with a rate of 19% for Brooker grade ≥2 in the patients who did not receive NSAID prophylaxis. No HO was found in the patients who received short-term COX-2 inhibitor prophylaxis. The short-term administration of 600 mg etodolac once daily for 2 weeks was found to be safe and effective in preventing HO in patients undergoing hip arthroscopic surgery. HO prophylaxis protocols based on short-term etodolac treatment may be considered after hip arthroscopic surgery.
Source: The American Journal of Sports Medicine - Category: Sports Medicine Authors: Rath, E., Warschawski, Y., Maman, E., Dolkart, O., Sharfman, Z. T., Salai, M., Amar, E. Tags: Hip/Pelvis/Thigh, Hip, femoroactabular impingement, Hip arthroscopy, NSAIDS Hip and Thigh Source Type: research
More News: Arthroscopy | Bleeding | Etodolac | Gastroenterology | Pain | Radiography | Sports Medicine | Study